253 related articles for article (PubMed ID: 30478891)
1. Clozapine and all-cause mortality in treatment-resistant schizophrenia: a historical cohort study.
Cho J; Hayes RD; Jewell A; Kadra G; Shetty H; MacCabe JH; Downs J
Acta Psychiatr Scand; 2019 Mar; 139(3):237-247. PubMed ID: 30478891
[TBL] [Abstract][Full Text] [Related]
2. The effect of clozapine on premature mortality: an assessment of clinical monitoring and other potential confounders.
Hayes RD; Downs J; Chang CK; Jackson RG; Shetty H; Broadbent M; Hotopf M; Stewart R
Schizophr Bull; 2015 May; 41(3):644-55. PubMed ID: 25154620
[TBL] [Abstract][Full Text] [Related]
3. Validation of an algorithm-based definition of treatment resistance in patients with schizophrenia.
Ajnakina O; Horsdal HT; Lally J; MacCabe JH; Murray RM; Gasse C; Wimberley T
Schizophr Res; 2018 Jul; 197():294-297. PubMed ID: 29472163
[TBL] [Abstract][Full Text] [Related]
4. Gender disparities in clozapine prescription in a cohort of treatment-resistant schizophrenia in the South London and Maudsley case register.
Wellesley Wesley E; Patel I; Kadra-Scalzo G; Pritchard M; Shetty H; Broadbent M; Segev A; Patel R; Downs J; MacCabe JH; Hayes RD; de Freitas DF
Schizophr Res; 2021 Jun; 232():68-76. PubMed ID: 34022618
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
[TBL] [Abstract][Full Text] [Related]
6. Ethnic inequalities in clozapine use among people with treatment-resistant schizophrenia: a retrospective cohort study using data from electronic clinical records.
de Freitas DF; Patel I; Kadra-Scalzo G; Pritchard M; Shetty H; Broadbent M; Patel R; Downs J; Segev A; Khondoker M; MacCabe JH; Bhui K; Hayes RD
Soc Psychiatry Psychiatr Epidemiol; 2022 Jul; 57(7):1341-1355. PubMed ID: 35246709
[TBL] [Abstract][Full Text] [Related]
7. Clozapine and its protective effect on all-cause, natural, and suicide mortality in patients with schizophrenia: A nationwide cohort study in Taiwan.
Chen WY; Chen PH; Pan CH; Su SS; Tsai SY; Chen CC; Kuo CJ
Schizophr Res; 2024 Jun; 268():150-160. PubMed ID: 37479588
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders.
Thompson JV; Clark JM; Legge SE; Kadra G; Downs J; Walters JT; Hamshere ML; Hayes RD; Taylor D; MacCabe JH
J Psychopharmacol; 2016 May; 30(5):436-43. PubMed ID: 26905920
[TBL] [Abstract][Full Text] [Related]
9. Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study.
Lin AS; Chan HY; Peng YC; Chen WJ
BMC Psychiatry; 2019 Jul; 19(1):220. PubMed ID: 31299940
[TBL] [Abstract][Full Text] [Related]
10. Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia.
Wimberley T; MacCabe JH; Laursen TM; Sørensen HJ; Astrup A; Horsdal HT; Gasse C; Støvring H
Am J Psychiatry; 2017 Oct; 174(10):990-998. PubMed ID: 28750580
[TBL] [Abstract][Full Text] [Related]
11. Elevated intrinsic cortical curvature in treatment-resistant schizophrenia: Evidence of structural deformation in functional connectivity areas and comparison with alternate indices of structure.
Torres-Carmona E; Ueno F; Iwata Y; Nakajima S; Song J; Mar W; Abdolizadeh A; Agarwal SM; de Luca V; Remington G; Gerretsen P; Graff-Guerrero A
Schizophr Res; 2024 Jul; 269():103-113. PubMed ID: 38761434
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of the evidence of clozapine's anti-aggressive effects.
Frogley C; Taylor D; Dickens G; Picchioni M
Int J Neuropsychopharmacol; 2012 Oct; 15(9):1351-71. PubMed ID: 22339930
[TBL] [Abstract][Full Text] [Related]
13. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies.
Masuda T; Misawa F; Takase M; Kane JM; Correll CU
JAMA Psychiatry; 2019 Oct; 76(10):1052-1062. PubMed ID: 31365048
[TBL] [Abstract][Full Text] [Related]
14. Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses.
Lally J; Ajnakina O; Di Forti M; Trotta A; Demjaha A; Kolliakou A; Mondelli V; Reis Marques T; Pariante C; Dazzan P; Shergil SS; Howes OD; David AS; MacCabe JH; Gaughran F; Murray RM
Psychol Med; 2016 Nov; 46(15):3231-3240. PubMed ID: 27605254
[TBL] [Abstract][Full Text] [Related]
15. Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia.
Wimberley T; Gasse C; Meier SM; Agerbo E; MacCabe JH; Horsdal HT
Schizophr Bull; 2017 Sep; 43(5):1064-1069. PubMed ID: 28184875
[TBL] [Abstract][Full Text] [Related]
16. Neuroimaging findings in treatment-resistant schizophrenia: A systematic review: Lack of neuroimaging correlates of treatment-resistant schizophrenia.
Nakajima S; Takeuchi H; Plitman E; Fervaha G; Gerretsen P; Caravaggio F; Chung JK; Iwata Y; Remington G; Graff-Guerrero A
Schizophr Res; 2015 May; 164(1-3):164-75. PubMed ID: 25684554
[TBL] [Abstract][Full Text] [Related]
17. Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.
Remington G; Lee J; Agid O; Takeuchi H; Foussias G; Hahn M; Fervaha G; Burton L; Powell V
Expert Opin Drug Saf; 2016 Sep; 15(9):1193-203. PubMed ID: 27207070
[TBL] [Abstract][Full Text] [Related]
18. Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone.
Hendouei N; Farnia S; Mohseni F; Salehi A; Bagheri M; Shadfar F; Barzegar F; Hoseini SD; Charati JY; Shaki F
Biomed Pharmacother; 2018 Jul; 103():965-972. PubMed ID: 29710513
[TBL] [Abstract][Full Text] [Related]
19. Combination of Clozapine With Long-Acting Injectable Antipsychotics in Treatment-Resistant Schizophrenia: Preliminary Evidence From Health Care Utilization Indices.
Grimminck R; Oluboka O; Sihota M; Rutherford DL; Yeung H
Prim Care Companion CNS Disord; 2020 Jul; 22(4):. PubMed ID: 32678523
[TBL] [Abstract][Full Text] [Related]
20. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).
Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J
Lancet; 2009 Aug; 374(9690):620-7. PubMed ID: 19595447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
